Amanta Healthcare (AMANTA) Stock Overview

Operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. More details

AMANTA fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	5/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 16.1% below our estimate of its fair value

Earnings grew by 168.8% over the past year

Risk Analysis

Interest payments are not well covered by earnings

Shares are highly illiquid

Does not have a meaningful market cap (₹5B)

AMANTA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Hoth Therapeutics

100% Patient Improvement in trial puts this $16M Biotech on the radar

Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.

131

US$5.3

70.2% undervalued

Jolt_Communications Fair Value

Revenue growth

N/A

Profit Margin

30%

Future PE

20x

Share price in 2030

US$0

Amanta Healthcare Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Amanta Healthcare
Historical stock prices
Current Share Price	₹137.45
52 Week High	₹154.40
52 Week Low	₹132.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.03%

Recent updates

Shareholder Returns

	AMANTA	IN Pharmaceuticals	IN Market
7D	-0.5%	1.4%	1.5%
1Y	n/a	-7.2%	-4.7%

Return vs Industry: Insufficient data to determine how AMANTA performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how AMANTA performed against the Indian Market.

Price Volatility

Is AMANTA's price volatile compared to industry and market?
AMANTA volatility
AMANTA Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.0%
Market Average Movement	5.2%
10% most volatile stocks in IN Market	8.3%
10% least volatile stocks in IN Market	3.2%

Stable Share Price: AMANTA's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine AMANTA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1994	522	Bhavesh Patel	www.amanta.co.in

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment.

Amanta Healthcare Limited Fundamentals Summary

How do Amanta Healthcare's earnings and revenue compare to its market cap?
AMANTA fundamental statistics
Market cap	₹5.34b
Earnings (TTM)	₹143.70m
Revenue (TTM)	₹2.72b

37.1x

P/E Ratio

2.0x

P/S Ratio

Is AMANTA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMANTA income statement (TTM)
Revenue	₹2.72b
Cost of Revenue	₹888.70m
Gross Profit	₹1.83b
Other Expenses	₹1.69b
Earnings	₹143.70m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	3.70
Gross Margin	67.32%
Net Profit Margin	5.28%
Debt/Equity Ratio	211.6%

How did AMANTA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/03 14:01
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amanta Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Amanta Healthcare LimitedNSEI:AMANTA Stock Report